Article No. 15
2026.08.26
Yakup News
SparkBioLabs is collaborating with Henry Ford Health in the United States to strengthen suicide prevention efforts. Drawing on Henry Ford Health's suicide prevention programs and operational experience, the partnership will explore approaches tailored to the Korean healthcare environment.
Article No. 14
2025.12.17
Maeil Business Newspaper
SparkBioLabs and IGIS Asset Management are joining forces to pursue life sciences real estate initiatives. The collaboration aims to leverage their respective expertise to develop research facilities and infrastructure that support the growth of biotechnology and healthcare companies.
Article No. 13
2025.12.11
Asia Economy
SparkBioLabs has officially launched as an accelerator specializing in biotechnology and healthcare startups. Through sector-focused investment and acceleration programs, the company aims to identify promising startups and support their growth.
Article No. 12
2025.11.18
Digital Today
SparkLabs Partners is advancing plans to establish a specialized clinical hospital. The initiative aims to support research and development and clinical collaboration for biotechnology and healthcare startups while strengthening partnerships between healthcare institutions and industry.
Article No. 11
2025.09.26
The Bio
SparkLabs Partners has opened a Gyeongbuk branch at Handong Global University to support regional biotechnology startups. The initiative aims to connect local research and startup infrastructure with investment networks, fostering the discovery and growth of promising biotechnology companies.
Article No. 10
2025.04.14
VentureSquare
SparkLabs will host a startup forum exploring the convergence of artificial intelligence and bio-health. The event will bring together industry stakeholders to discuss technological innovation, investment trends, and opportunities for startup growth and global expansion.
Article No. 9
2025.04.02
The Korea Economic Daily
Songdo, Incheon, is emerging as a biotechnology R&D hub through collaboration among companies and research institutions. SparkLabs and other organizations are supporting research, development, and commercialization efforts for biotechnology startups, contributing to the growth of the regional bio-innovation ecosystem.
Article No. 8
2025.01.22
The Bio
[The Bio Reporter Kang In-hyo] SparkBio, a specialized accelerator in the bio and healthcare field operated by Sparklab, a global accelerator (AC), announced on the 22nd that it signed a business agreement (MOU) with Pohang City on the 21st to establish a 'clinical specialized hospital'. The signing ceremony was held at 'Maru 360', a startup incubation center in Gangnam-gu, Seoul. Major organizations including SparkBio, Pohang City, Pohang City Council, and Pohang Global Enterprise Innovation Park participated. < From The Bio>
Article No. 7
2024.11.27
The Bio
[The Bio Reporter Kang In-hyo] An open innovation hub in the bio field will be established in Incheon's 'Songdo International Business District'. The Incheon Free Economic Zone Authority announced on the 27th that it signed a memorandum of understanding (MOU) for mutual cooperation to promote the 'SPARKPLEX' project at Incheon City Hall. Incheon Mayor Yoo Jeong-bok, Incheon Free Economic Zone Authority Commissioner Yoon Won-seok, Sparklab CEO Kim Ho-min, and Songdo International City Development Co., Ltd. CEO Park Cheol-ho attended the meeting to discuss the business plan and sign the agreement. The SparkPLEX development project is a project to develop two 35-story buildings in 'F3-3 Block (Songdo-dong 37-2)' of Songdo International Business District. Approximately KRW 500 billion will be invested in the project. <From The Bio >
Article No. 6
2024.11.26
Hit News
Sparklab announced on the 26th that it signed a business agreement with Partners Investment at the 'Mediopenlab Day' held at the Mediopenlab of the Korea Health Management Association in Gangseo-gu, Seoul on the 25th and will strengthen investment in and support for startups in the biohealthcare field.
Through the agreement, the two companies will support the following: △initial and follow-up investment, △evaluation of technology commercialization potential, △R&D consulting, and commercialization strategies for early-stage startups in the bio-healthcare sector. They will also collaborate on △establishing strategies to respond to the regulatory environment in the bio-healthcare sector, △providing joint research and consulting on national policy issues, △assessing expected risks at each investment stage, and establishing management strategies... <From Hit News>
Article No. 5
2024.10.08
Money Today
Global accelerator SparkLabs announced on the 8th that it signed a business agreement with Seoul National University Hospital’s Biomedical Research Institute to foster and promote investment in early-stage startups in the domestic bio and health fields.
Through this agreement, SparkLabs will promote support projects such as ▲ startup consulting in the bio-health field ▲ discovery and fostering of excellent early-stage startups ▲ joint research and promotional activities ▲ investment linkage, together with Seoul National University Hospital’s Biomedical Research Institute, based on the shared laboratory platform ‘Mediopenlab’ and infrastructure equipped with cutting-edge research facilities worth approximately KRW 2 billion. (From Money Today)
Article No. 4
2024.10.29
The Bio
'We aim to support innovative technologies and businesses that improve the quality of life of patients and their families.' This is the mission of 'SparkBioLab,' launched last year by SparkLabs, a global accelerator (AC), to discover and foster promising domestic bio and healthcare startups. SparkBioLab, a specialized bio and healthcare investment company, opened 'MediopenLab,' the first shared laboratory in Korea operated by a medical examination institution, in April of this year in collaboration with the Korea Health Management Association... <From TheBio>
Article No. 3
2024.09.13
Maeil Kyungjae
SparkLabs, Yonsei University Biohealth Technology Holdings and Bio Startup Support
'We aim to support innovative technologies and businesses that improve the quality of life of patients and their families.' This is the mission of 'SparkBioLab,' launched last year by SparkLabs, a global accelerator (AC), to discover and foster promising domestic bio and healthcare startups. SparkBioLab, a specialized bio and healthcare investment company, opened 'MediopenLab,' the first shared laboratory in Korea operated by a medical examination institution, in April of this year in collaboration with the Korea Health Management Association... < From The Bio>
Article No. 2
2024.08.28
Pharmaceutical Newspaper
SparkBioLabs (CEO Hong-Joo Lee) announced on the 28th that the seminar it co-hosted with Oracle Korea at COEX on the topic of 'Fusion of Innovative Biotechnology and Cloud Data Analysis' on the 27th was successfully concluded with approximately 50 attendees.
SparkBioLab is a bio-specialized accelerator launched by global startup accelerator SparkLab to discover and foster high-capability startups. This seminar was designed to share the latest information useful to researchers and industry professionals by introducing innovative research results that combine biotechnology and data analysis. <From the Yakup Shinmun>
Article No. 1
2024.04.16
Yonhap News
Seoul = Yonhap News) Reporter Hong Guk-gi = SparkLabs, an early-stage startup accelerator (an organization that fosters startups through investment and mentoring), announced on the 16th that it will open a platform specializing in fostering bio and health startups called 'Mediopenlab' and begin full-scale operation. Mediopenlab is a platform established by the Korea Health Management Association and operated by SparkLabs' specialized accelerator 'SparkBiolab' to expand the discovery and fostering of bio and health startups. Mediopenlab's 'shared laboratory' established within the headquarters of the Health Management Association in Deungchon-dong, Gangseo-gu, Seoul, has state-of-the-art research facilities worth 2 billion won and a digital healthcare analysis area where health checkup data can be utilized for research. <Excerpt from Yonhap News>